nonsense. "Pursuant to this prospectus supplement and the accompanying prospectus, we are offering 8,027,632 shares of our voting common stock to Terrapin Opportunity, L.P., or Terrapin, pursuant to a Common Stock Purchase Agreement between us and Terrapin dated as of August 7, 2015, which we refer to as the Purchase Agreement, at a price of approximately $0.80 per share. The total purchase price for the shares is approximately $6.5 million."
Should not be any problem paying the COFACE principal and interest on December 15th. That still leaves ~$25 million remaining equity cure funds under the Terrapin agreement through July 15, 2017. The company is only taking what it needs, as needed.
the company is taking less than expected - a good sign.
from satfi
News 
Market Data 
Discover 
